Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder
Top Cited Papers
- 18 January 2022
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 231, 109254
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse (1UG1DA050067–01, 3UG3DA044830–02S1)
This publication has 22 references indexed in Scilit:
- A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-releaseDrug and Alcohol Dependence, 2017
- Cost‐effectiveness of extended release naltrexone to prevent relapse among criminal justice‐involved individuals with a history of opioid use disorderAddiction, 2017
- The costs of crime during and after publicly funded treatment for opioid use disorders: a population‐level study for the state of CaliforniaAddiction, 2016
- Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based CareJournal of Addictive Diseases, 2015
- Pharmacological interventions for drug-using offendersCochrane Database of Systematic Reviews, 2015
- Impact of Methadone Maintenance Treatment on Women Offenders' Post-Release RecidivismEuropean Addiction Research, 2014
- Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009Annals of Internal Medicine, 2013
- Postprison Release HIV‐Risk Behaviors in a Randomized Trial of Methadone Treatment for PrisonersThe American Journal on Addictions, 2012
- Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trialDrug and Alcohol Dependence, 2009
- Using Administrative Data for Longitudinal Substance Abuse ResearchThe Journal of Behavioral Health Services & Research, 2008